Health economics: the end of clinical freedom?
作者信息
Williams A
机构信息
Institute for Research in the Social Sciences, University of York.
出版信息
BMJ. 1988 Nov 5;297(6657):1183-6. doi: 10.1136/bmj.297.6657.1183.
Abstract
摘要
相似文献
1
Health economics: the end of clinical freedom?健康经济学：临床自主权的终结？
BMJ. 1988 Nov 5;297(6657):1183-6. doi: 10.1136/bmj.297.6657.1183.
2
Enough wiggle room.足够的回旋余地。
Hastings Cent Rep. 1992 Nov-Dec;22(6):43-4.
3
Professional integrity and global budgeting: a study of physician gatekeeping in the British National Health Service.
Prof Ethics. 1993 Spring-Summer;2(1-2):3-34.
4
Ethical dilemmas in the care of the ill. I. What is the physician's service?照顾病患中的伦理困境。一、医生的职责是什么？
JAMA. 1980 Oct 17;244(16):1811-6.
5
From global rationing to target setting in the U.K.从全球配给到英国的目标设定
Hastings Cent Rep. 1989 Jul-Aug;19(4):S3-4.
6
[The origin of informed consent].[知情同意的起源]
Acta Otorhinolaryngol Ital. 2005 Oct;25(5):312-27.
7
Bioethics and the liberal state: Just Doctoring: Medical Ethics in the Liberal State, by Troyen A. Brennan.生物伦理学与自由国家：《公正行医：自由国家中的医学伦理》，作者特罗延·A·布伦南
J Clin Ethics. 1993 Spring;4(1):92-5.
8
Health care rationing and professional integrity: not necessarily incompatible.医疗资源分配与职业操守：未必相互矛盾。
APA Newsl Philos Med. 1993 Spring;92(1):80-5.
9
Just Doctoring: Medical Ethics in the Liberal State, by Troyen Brennan.《公正行医：自由国家中的医学伦理》，作者特罗延·布伦南。
Am J Law Med. 1992;18(1-2):163-70.
10
The ethics of cost-containment: bureaucratic medicine and the doctor as patient-advocate.成本控制的伦理：官僚化医疗与作为患者权益倡导者的医生
Notre Dame J Law Ethics Public Policy. 1988 Winter;3(2):187-225.
引用本文的文献
1
Maintaining Clinical Freedom Whilst Achieving Value in Biologics Prescribing: An Integrated Cross-Specialty Consensus of UK Dermatologists, Rheumatologists and Gastroenterologists.在实现生物制剂处方价值的同时保持临床自由：英国皮肤科医生、风湿病学家和胃肠病学家的综合跨专业共识。
BioDrugs. 2021 Mar;35(2):187-199. doi: 10.1007/s40259-020-00464-5. Epub 2021 Feb 26.
2
Pharmaceutical cost control in primary care: opinion and contributions by healthcare professionals.基层医疗中的药品成本控制：医疗专业人员的观点与贡献
BMC Health Serv Res. 2009 Nov 18;9:209. doi: 10.1186/1472-6963-9-209.
3
The generalisability of pharmacoeconomic studies: issues and challenges ahead.药物经济学研究的可推广性：未来的问题与挑战
Pharmacoeconomics. 2006;24(10):937-45. doi: 10.2165/00019053-200624100-00001.
4
Trust and performance management in the medical marketplace.医疗市场中的信任与绩效管理。
J R Soc Med. 2003 Nov;96(11):532-9. doi: 10.1177/014107680309601105.
本文引用的文献
1
Cost should not be a factor in medical care.费用不应成为医疗保健中的一个因素。
N Engl J Med. 1980 Mar 20;302(12):697. doi: 10.1056/NEJM198003203021226.
2
The end of clinical freedom.临床自由的终结。
Br Med J (Clin Res Ed). 1983 Oct 29;287(6401):1237-8. doi: 10.1136/bmj.287.6401.1237.
3
Passive exposure to tobacco smoke: saliva cotinine concentrations in a representative population sample of non-smoking schoolchildren.被动接触烟草烟雾：非吸烟学童代表性人群样本中的唾液可替宁浓度
Br Med J (Clin Res Ed). 1985 Oct 5;291(6500):927-9. doi: 10.1136/bmj.291.6500.927.
4
Comparison of tests used to distinguish smokers from nonsmokers.用于区分吸烟者和非吸烟者的测试比较。
Am J Public Health. 1987 Nov;77(11):1435-8. doi: 10.2105/ajph.77.11.1435.
5
Initiating and withdrawing life support. Principles and practice in adult medicine.
N Engl J Med. 1988 Jan 7;318(1):25-30. doi: 10.1056/NEJM198801073180106.
Zotero 插件